Personalized biocorona as disease biomarker: The challenges and opportunities

被引:1
|
作者
Talab, Mahtab Jahanshah [1 ]
Valizadeh, Ali [1 ]
Tahershamsi, Zahra [1 ]
Housaindokht, Mohammad Reza [2 ]
Ranjbar, Bijan [1 ]
机构
[1] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran
[2] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Biophys Chem Lab, Mashhad, Iran
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2024年 / 1868卷 / 12期
关键词
Personalized protein corona; Biocorona; And nanomaterial; NANOPARTICLE-PROTEIN CORONA; ENABLED BLOOD-TEST; HUMAN PLASMA; GOLD NANOPARTICLES; MUSHROOM TYROSINASE; BIOLOGICAL IDENTITY; CIRCULAR-DICHROISM; CANCER; ADSORPTION; DISCOVERY;
D O I
10.1016/j.bbagen.2024.130724
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is well known that when nanoparticles interact with biological fluids, a layer of proteins and biological components forms on them. This layer may alter the biological fate and efficiency of the nanomaterial. Recent studies have shown that illness states have a major impact on the structure of the biocorona, sometimes referred to as the "personalized protein corona." Physiological factors like illness, which impact the proteome and metabolome pattern and result in conformational changes in proteins, give rise to this structure of discrimination in biocorona decoration. Improving the efficiency of precise platforms for developing new molecular biomarkers for accurate illness diagnosis is vitally necessary. The biocorona pattern's discrimination may be a diagnostic tool for designing biosensors. As a result, in this review, we summarize the most current studies on the relationship between physiological conditions and the variety of biocorona patterns that influence the biological responses of nanosystems. The biocorona pattern's flexibility may provide new research directions and be utilized to create nanoparticle-based therapeutic and diagnostic products suited to certain physiological situations.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment
    Lucs, Alexandra V.
    Saltman, Benjamin
    Chung, Christine H.
    Steinberg, Bettie M.
    Schwartz, David L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (02): : 294 - 306
  • [2] Challenges and Opportunities for Biomarker Validation
    Hey, Spencer Phillips
    D'Andrea, Elvira
    Jung, Emily H.
    Tessema, Frazer
    Luo, Jing
    Gyawali, Bishal
    Kesselheim, Aaron S.
    JOURNAL OF LAW MEDICINE & ETHICS, 2019, 47 (03): : 357 - 361
  • [3] PERSONALIZED MEDICINE PRESENTS CHALLENGES AND OPPORTUNITIES
    Levenson, Deborah
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (02) : VII - VIII
  • [4] Personalized treatment in the epilepsies: challenges and opportunities
    Balestrini, Simona
    Sisodiya, Sanjay M.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (04): : 237 - 247
  • [5] Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities
    Song Li
    Weidong Le
    Neuroscience Bulletin, 2017, (05) : 481 - 482
  • [6] Biomarker Discovery in Parkinson’s Disease: Present Challenges and Future Opportunities
    Song Li
    Weidong Le
    Neuroscience Bulletin, 2017, 33 : 481 - 482
  • [7] Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities
    Li, Song
    Le, Weidong
    NEUROSCIENCE BULLETIN, 2017, 33 (05) : 481 - 482
  • [8] Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities
    Fabbri, Margherita
    Coelho, Miguel
    Garon, Michela
    Biundo, Roberta
    Mestre, Tiago A.
    Antonini, Angelo
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [9] Assembloid learning: opportunities and challenges for personalized approaches to brain functioning in health and disease
    Mencattini, Arianna
    Daprati, Elena
    Della-Morte, David
    Guadagni, Fiorella
    Sangiuolo, Federica
    Martinelli, Eugenio
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2024, 7
  • [10] Challenges and opportunities for oncology biomarker discovery
    Deyati, Avisek
    Younesi, Erfan
    Hofmann-Apitius, Martin
    Novac, Natalia
    DRUG DISCOVERY TODAY, 2013, 18 (13-14) : 614 - 624